Table 1.
Characteristics at baseline of lung cancer resection patients.
| Characteristics | Years | p-Value (Comparison between the 3 Years) | 2020 SARS-CoV-2 Patients | 2020 Non-SARS-CoV-2 Patients | |||||
|---|---|---|---|---|---|---|---|---|---|
| 2018 | 2019 | 2020 | Characteristics | p-Value (Comparison with 2019) | Characteristics | p-Value (Comparison with 2019) | p-Value (Comparison with 2020 SARS-CoV-2) | ||
| Hospitalized patients with lung cancer resection (n) | 12,153 | 12,227 | 11,634 | 51 | 11,583 | ||||
| Age Mean +/− std | 65 +/− 10 ‡ | 66 +/− 10 | 66 +/− 10 | 0.0002 | 68 +/− 8 | 0.0615 | 66 +/− 10 | 0.8598 | 0.0641 |
| Median (Q1–Q3) | 66 (60–72) | 67 (60–72) | 67 (60–73) | 70 (61–73) | 67 (60–73) | ||||
| Min-Max | 18–92 | 18–91 | 18–94 | 50–85 | 18–94 | ||||
| Men (%) | 63.4 * | 62 * | 60.6 | <0.0001 | 62.8 | 0.9150 | 60.6 | 0.0204 | 0.7494 |
| Pulmonary disease (%) | 33.1 * | 31.6 | 30.9 | 0.0012 | 72.6 | <0.0001 | 30.8 | 0.1494 | <0.0001 |
| Heart disease (%) | 15.7 | 15.5 | 16.3 | 0.1949 | 11.8 | 0.4638 | 16.3 | 0.0782 | 0.3798 |
| Peripheral vascular disease (%) | 9.7 | 9.2 | 9.1 | 0.1926 | 11.8 | 0.4668 | 9.1 | 0.8200 | 0.4693 |
| Neurological disease (%) | 4.2 | 4.1 | 4.3 | 0.6038 | 9.8 | 0.0560 | 4.3 | 0.3663 | 0.0678 |
| Liver disease (%) | 0.9 | 1 | 0.8 | 0.1705 | 2 | 0.3946 | 0.8 | 0.0643 | 0.3216 |
| Renal disease (%) | 2.9 | 2.8 | 3.1 | 0.2805 | 3.9 | 0.6523 | 3.1 | 0.1161 | 0.6725 |
| Endocrine disease (%) | 12.6 | 12.6 | 12.9 | 0.6701 | 21.6 | 0.0557 | 12.9 | 0.5711 | 0.0649 |
| Metabolic disease (%) | 14.1 | 13.7 | 13.8 | 0.6054 | 29.4 | 0.0012 | 13.7 | 0.9888 | 0.0012 |
| Infectious disease (%) | 0.6 | 0.7 | 0.6 | 0.7268 | 2 | 0.2959 | 0.6 | 0.4208 | 0.2654 |
| Hematological disease (%) | 5.2 | 5.3 | 5.2 | 0.9183 | 7.8 | 0.3506 | 5.2 | 0.6855 | 0.3411 |
| Other malignant lesions (%) | 43.4 * | 41.7 | 41.8 | 0.0116 | 45.1 | 0.6253 | 41.8 | 0.9497 | 0.6295 |
| Other therapies (%) | 11.2 * | 9.4 | 9.5 | <0.0001 | 9.8 | 0.8112 | 9.5 | 0.7757 | 0.8131 |
| Charlson index (%) | 0.0084 | 0.0238 | 0.0013 | 0.0199 | |||||
| 0 | 43.5 | 43.9 | 44.5 | 25.5 | 44.6 | ||||
| 1 | 24 | 24.9 | 22.8 | 35.3 | 22.8 | ||||
| 2 | 8 | 7.7 | 7.9 | 13.7 | 7.9 | ||||
| ≥3 | 24.6 | 23.5 | 24.8 | 25.5 | 24.8 | ||||
Std: standard deviation; (Q1–Q3): interquartile range; * significantly more frequent compared to 2020 (p < 0.05); ‡ significantly less frequent compared to 2020 (p < 0.05).